Claims for Patent: 5,846,774

Summary for Patent: 5,846,774

Title:	Chlorella virus promoters
Abstract:	The present invention provides novel promoter sequences obtained from Chlorella virus. The invention includes gene constructs comprising a promoter sequence of the invention operably linked to a DNA sequence encoding a structural gene. The invention also provides vectors and host cells for expressing a product encoded by the structural gene of a gene construct of the invention and cells transformed with the heterologous gene operably linked to the promoter.
Inventor(s):	Xia; Yuannan (Lincoln, NE)
Assignee:	BioNebraska, Inc. (Lincoln, NE)
Application Number:	08/821,559
Patent Claims:	1. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 1. 2. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 2. 3. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 3. 4. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 4. 5. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 5. 6. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 6. 7. A vector comprising the nucleic acid sequence set forth as SEQ ID NO: 7. 8. A gene construct comprising a promoter operably linked to a heterologous structural gene, said promotor comprising the nucleic acid sequence set forth as SEQ ID NO: 1,2,3,4,5,6,or7. 9. The gene construct of claim 8, wherein said structural gene encodes carbonic anhydrase. 10. The gene construct of claim 9, wherein said carbonic anhydrase is human carbonic anhydrase. 11. The gene construct of claim 8, wherein said structural gene encodes glucagon-like peptide-1, growth hormone releasing factor, or parathyroid hormone. 12. A host cell containing a gene construct comprising a promotor operably linked to a heterologous structural gene, said promotor comprising the nucleic acid sequence set forth as SEQ ID NO: 1, 2, 3, 4, 5, 6, or 7. 13. The host cell of claim 12, wherein said host cell is a prokaryotic cell. 14. The host cell of claim 13, wherein said prokaryotic cell is an E. coli cell. 15. The host cell of claim 14, wherein said E. coli cell is a HB101 cell or JM109 cell. 16. A process for producing a protein, said process comprising: transforming a host cell with a gene construct comprising a promotor operably linked to a structure gene, said promotor comprising a nucleic acid sequence set forth as SEQ ID NO: 1,2,3,4,5,6, or 7;and culturing the host cell under conditions whereby the protein is expressed. 17. The process of claim 16, further comprising the step: isolating the expressed protein from the host cell. 18. A process for producing a protein said process comprising: incubating a host cell under conditions whereby the protein is expressed, which host cell comprises a gene construct comprising a promotor operably liked to a heterologous nucleic acid sequence encoding the protein, said promoter comprising a nucleic acid sequence as set forth as SEQ ID NO: 1, 2, 3, 4, 5, 6, or 7. 19. The process of claim 18, further comprising the step: isolating the expressed protein from the host cell.

Details for Patent 5,846,774

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-03-29